1,9-dideoxyforskolin has been researched along with dronabinol in 1 studies
Studies (1,9-dideoxyforskolin) | Trials (1,9-dideoxyforskolin) | Recent Studies (post-2010) (1,9-dideoxyforskolin) | Studies (dronabinol) | Trials (dronabinol) | Recent Studies (post-2010) (dronabinol) |
---|---|---|---|---|---|
111 | 0 | 2 | 8,307 | 785 | 3,094 |
Protein | Taxonomy | 1,9-dideoxyforskolin (IC50) | dronabinol (IC50) |
---|---|---|---|
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.218 | |
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0028 | |
Cannabinoid receptor 2 | Homo sapiens (human) | 0.0095 | |
Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.218 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, SA; Lichtman, AH; Martin, BR; Welch, SP | 1 |
1 other study(ies) available for 1,9-dideoxyforskolin and dronabinol
Article | Year |
---|---|
Evaluation of cAMP involvement in cannabinoid-induced antinociception.
Topics: Analgesics; Animals; Colforsin; Cyclic AMP; Cyclohexanols; Dronabinol; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley | 1995 |